Conejo-Garcia J - Search Results

1

Mesothelin, a novel immunotherapy target for triple negative breast cancer.

Tchou J, Wang LC, Selven B, Zhang H, Conejo-Garcia J, Borghaei H, Kalos M, Vondeheide RH, Albelda SM, June CH, Zhang PJ. Tchou J, et al. Breast Cancer Res Treat. 2012 Jun;133(2):799-804. doi: 10.1007/s10549-012-2018-4. Epub 2012 Mar 15. Breast Cancer Res Treat. 2012. PMID: 22418702 Free PMC article.

2

Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells.

Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G. Conejo-Garcia JR, et al. Cancer Res. 2004 Mar 15;64(6):2175-82. doi: 10.1158/0008-5472.can-03-2194. Cancer Res. 2004. PMID: 15026360

3

Chimeric NKG2D receptor-bearing T cells as immunotherapy for ovarian cancer.

Barber A, Zhang T, DeMars LR, Conejo-Garcia J, Roby KF, Sentman CL. Barber A, et al. Cancer Res. 2007 May 15;67(10):5003-8. doi: 10.1158/0008-5472.CAN-06-4047. Cancer Res. 2007. PMID: 17510432

4

Targeting the tumor stroma as a novel treatment strategy for breast cancer: shifting from the neoplastic cell-centric to a stroma-centric paradigm.

Tchou J, Conejo-Garcia J. Tchou J, et al. Adv Pharmacol. 2012;65:45-61. doi: 10.1016/B978-0-12-397927-8.00003-8. Adv Pharmacol. 2012. PMID: 22959023 Review.

5

Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancer.

Tchou J, Zhang PJ, Bi Y, Satija C, Marjumdar R, Stephen TL, Lo A, Chen H, Mies C, June CH, Conejo-Garcia J, Puré E. Tchou J, et al. Hum Pathol. 2013 Nov;44(11):2549-57. doi: 10.1016/j.humpath.2013.06.016. Epub 2013 Sep 26. Hum Pathol. 2013. PMID: 24074532 Free PMC article.

6

Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer.

Rutkowski MR, Allegrezza MJ, Svoronos N, Tesone AJ, Stephen TL, Perales-Puchalt A, Nguyen J, Zhang PJ, Fiering SN, Tchou J, Conejo-Garcia JR. Rutkowski MR, et al. J Vis Exp. 2014 Mar 26;(85):51171. doi: 10.3791/51171. J Vis Exp. 2014. PMID: 24748051 Free PMC article.

7

Fibroblast activation protein, a potential diagnostic and therapeutic target for cancer-reply.

Tchou J, Conejo-Garcia J. Tchou J, et al. Hum Pathol. 2014 Jul;45(7):1553-4. doi: 10.1016/j.humpath.2013.11.022. Epub 2014 Mar 26. Hum Pathol. 2014. PMID: 24792620 No abstract available.

8

Mesothelin expression is associated with poor outcomes in breast cancer.

Li YR, Xian RR, Ziober A, Conejo-Garcia J, Perales-Puchalt A, June CH, Zhang PJ, Tchou J. Li YR, et al. Breast Cancer Res Treat. 2014 Oct;147(3):675-84. doi: 10.1007/s10549-014-3077-5. Epub 2014 Sep 6. Breast Cancer Res Treat. 2014. PMID: 25193277 Free PMC article.

9

Transforming growth factor β-mediated suppression of antitumor T cells requires FoxP1 transcription factor expression.

Stephen TL, Rutkowski MR, Allegrezza MJ, Perales-Puchalt A, Tesone AJ, Svoronos N, Nguyen JM, Sarmin F, Borowsky ME, Tchou J, Conejo-Garcia JR. Stephen TL, et al. Immunity. 2014 Sep 18;41(3):427-439. doi: 10.1016/j.immuni.2014.08.012. Immunity. 2014. PMID: 25238097 Free PMC article.

10

Reprogramming immune responses via microRNA modulation.

Cubillos-Ruiz JR, Rutkowski MR, Tchou J, Conejo-Garcia JR. Cubillos-Ruiz JR, et al. Microrna Diagn Ther. 2013 Apr 26;1(1):2013-0001. doi: 10.2478/micrnat-2013-0001. Microrna Diagn Ther. 2013. PMID: 25285232 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

195 results

Search Page